| 1 |
34392440 | Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition. | 2021 Sep |
2 |
| 2 |
33178028 | Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway. | 2020 |
1 |
| 3 |
30116169 | Cytotoxic Profiling of Endogenous Metabolites Relevant to Chronic Fatigue Immune Dysfunction Syndrome (CFIDS) on p53 Variant Human Colon Carcinoma Cell Lines. | 2018 Jul-Sep |
2 |
| 4 |
24421392 | c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. | 2014 Mar |
1 |
| 5 |
19728331 | Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. | 2010 Apr 1 |
1 |
| 6 |
20500145 | Targeting the p53 pathway of apoptosis. | 2010 |
1 |
| 7 |
19822456 | p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. | 2009 Nov |
2 |
| 8 |
16157218 | Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells. | 2005 Nov 8 |
2 |